STIC-RISC study

Thank you for having a look on this web page! 

The STIC-RISC study has recently started and we are currently working on starting the study in several new centers: both in the Netherlands and across the world! 

The STIC-RISC study is a retrospective and prospective registration study. In this study, women who are diagnosed with a STIC or STIL lesion are included and followed to see whether or not they develop peritoneal cancer or other types of abdominal cancer. The aim of the study is to assess peritoneal cancer incidence and identify histopathological characteristics of STIL/STIC which are reproducible and asssociated with the risk of peritoneal cancer. 

If you are interested in particpating with your center of would like to propose a patient, please contact stic-risc@radboudumc.nl 

E-learning about diagnosing precursor lesions of high-grade serous cancer

We designed this e-learning for pathologists and pathologists in training and concerns pelvic high-grade serous carcinoma (HGSC) and its precursor lesions. This e-learning focuses on diagnosing and differentiating between the several putative precursors of HGSC and related lesions including serous tubal intraepithelial carcinoma (STIC), serous tubal intraepithelial lesion (STIL), and p53 signature. It contains examples which can be viewed in a ‘real-life’ setting using digitalized whole slide images. At the end of this e-learning, you can examine your knowledge with a ‘‘test yourself’’.